Our clinical development programs:

1a-1

1a-2

1a-3

1a-4

1b

Neurocentria’s Candidate Compound MMFS Improves Brain Age by 9 Years in Human Study on Older Adults

Data from double-blind placebo-controlled clinical trial, now published in the Journal of Alzheimer’s Disease , supports ongoing studies in early Alzheimer’s patients

View press release